This $2,777,976 Cooperative Agreement, awarded by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program, aims to improve the response to HIV and ensure sustained epidemic control in targeted areas of the Democratic Republic of Congo (DRC). The primary awardee, Family Health International (FHI 360), will implement activities to decrease new HIV infections and reduce HIV-associated morbidity and mortality in the...
This $300,000 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Global AIDS (CFDA 93.067) program supports the "TOTAL CONTROL OF THE EPIDEMIC TCE KINSHASA" project implemented by Humana People To People Congo (HPP-Congo) in Kinshasa, Democratic Republic of the Congo. The project aims to strengthen systematic, people-centered approaches to HIV/TB prevention, detection, and treatment, while improving clinical and community-based services...
This Cooperative Agreement award from the U.S. Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) provides $11,097,080 to Global Health Systems Solutions (GHSS) to build and improve integrated laboratory capacity and quality services in the Democratic Republic of the Congo (DRC). The key objectives are to: 1) scale up quality assurance and improvement for HIV rapid testing and TB sites; 2) expand quality testing for viral load, early infant diagnosis,...
The Cooperative Agreement award, Federal Grant Award ID NU2GGH002528, was provided by the Centers for Disease Control and Prevention (CDC) under the Global AIDS Federal Grant Program (CFDA 93.067) to the Association De Sante Familiale, a local non-profit organization, and PATH, a U.S.-based international NGO. The $6,749,031 award aims to enhance access to comprehensive HIV/AIDS services and achieve epidemic control in seven health zones in Haut-Katanga Province, Democratic Republic of the...
This $3,371,050 Cooperative Agreement awarded by the U.S. Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) aims to strengthen the delivery of quality and equitable public health services for the prevention, testing, care, and treatment of HIV in Jamaica and Trinidad and Tobago under the President's Emergency Plan for AIDS Relief (PEPFAR). The primary strategies are to: 1) Strengthen comprehensive HIV prevention and testing services for the general...
This Cooperative Agreement award from the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program is intended to scale up and improve the management of drug-resistant tuberculosis (DR-TB) in USAID-supported countries. The $287,878,180 award, with a project period from October 1, 2024 to September 30, 2029, will focus on expanding access to high-quality DR-TB treatment services and providing specialized technical assistance to...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $7,410,542 Cooperative Agreement under the Global AIDS program (CFDA 93.067) to the Center for Family Health Research (CFHR) to implement the "INGANJI RWANDA: EVIDENCE-BASED HIV PREVENTION AND CARE FOR KEY AND PRIORITY POPULATIONS" project in Rwanda. The 5-year project (9/30/2024 - 9/29/2029) aims to: 1) Optimize access to and use of evidence-based HIV interventions among key and priority populations (KP/PP) in...
This Cooperative Agreement award, provided by the U.S. Agency for International Development (USAID) under the Foreign Assistance Program (CFDA 98.001), aims to increase the utilization of quality HIV prevention and treatment services in Tanzania through community-led monitoring activities. The $2,100,000 project, which runs from January 1, 2025 to December 31, 2029, will be implemented by the National Council of People Living with HIV/AIDS (NACOPHA) in close collaboration with the Government...
This federal Cooperative Agreement award, provided by the U.S. Department of Health and Human Services' Centers for Disease Control and Prevention under the Global AIDS program (CFDA 93.067), will support the Cameroon Baptist Convention Health Board to develop, implement, and sustain high-quality comprehensive HIV cascade activities for children, adolescents, and adults in facility and community-based settings in Cameroon under the President's Emergency Plan for AIDS Relief (PEPFAR). The...
This Cooperative Agreement award, provided by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas program (CFDA 98.001), aims to achieve sustainable, equitable, and resilient health systems through locally led, evidence-driven, and context-specific approaches to health system strengthening. The $6,545,200 award, with a period of performance from December 19, 2024 to December 18, 2029, is granted to Family Health International (FHI 360), a...